Noninvasive Ventilation Before Maximum Exercise Test Increases Exercise Tolerance in Subjects With Heart Failure: A...

Area of Science:

• Cardiology
• Pulmonology
• Exercise Physiology

Background:

• Heart failure (HF) is a complex condition characterized by reduced exercise capacity.
• Noninvasive ventilation (NIV) is a therapeutic modality that can support respiratory function.

Purpose of the Study:

• To investigate the impact of noninvasive ventilation (NIV) on the exercise performance of individuals diagnosed with heart failure (HF).

Main Methods:

• A crossover, blind, randomized controlled trial was conducted in a university research laboratory.
• Twenty-four participants with New York Heart Association class II and III left heart failure underwent cardiopulmonary exercise testing (CPET) with and without NIV.
• NIV was applied via a facemask at two pressure levels (IPAP 15 cmH2O, EPAP 5 cmH2O) for 30 minutes prior to CPET.

Main Results:

• Maximal oxygen consumption increased significantly with NIV (20.6±4.9 mL·kg−1·min−1) compared to the nonintervention phase (18.3±4.4 mL·kg−1·min−1; P=.01).
• Heart rate response (P=.04) and heart rate variation (P=.02) showed significant improvements during CPET with NIV.
• Cardiopulmonary exercise duration increased (P=.01), and oxygen consumption recovery time decreased (P=.01) with NIV.

Conclusions:

• Noninvasive ventilation demonstrates beneficial effects in heart failure patients, enhancing exercise tolerance.
• NIV improves chronotropic and respiratory reserves, optimizing recovery time post-exercise.
• This study suggests NIV as a potential supportive therapy to improve exercise capacity in individuals with heart failure.